BioCopy develops AI- and automation-based platforms for accelerated drug developmentThe main focus is on biotherapeutics in oncology. Through Data-driven analysis and high-throughput screening processes suitable drug candidates are identified and evaluated more quickly.

The approach significantly shortens development times and at the same time improves the assessment of potential safety risks - a New efficiency standard in biopharmaceutical research.